BeStock  

Amylyx Pharmaceuticals AMLX

US equityMarket cap rank #2350Drug Manufacturers - Specialty & Generic
$26.02 −$0.18 (-0.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.55 -1.81%
Open$25.64
Prev close$26.20
Day range$25.52 – $26.40
Volume1.14M
Market cap$3.35B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership97.8%-8.92 pts vs. prior quarter
Institutions holding254+14 vs. prior quarter
Insider trades (recent)22 buys / 28 sellsNet selling
Short interest10.22% of floatDays to cover 10.5 · as of 30 Oct 2026
Short-sale volume share24.1%5-day average of daily volume

Short-sale volume as % of daily volume

11%18%25%32%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$7.85M (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

−$10.8MSuper+$3.0MBig+$4.1MMid+$8.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 39.3% of shares outstanding.

Largest holders

  • FMR15.51%
  • BlackRock8.06%
  • Perceptive Advisors LLC6.48%
  • TCG Crossover Management, LLC4.86%
  • Commodore Capital LP4.39%
  • Janus Henderson Group plc4.07%
  • Vanguard Capital Management, LLC3.95%
  • Saturn V Capital Management LP3.60%

By investor type

  • Mutual Fund57.72%
  • Hedge Fund19.65%
  • VC/PE Fund13.96%
  • Individual/Insider5.91%
  • Public Company4.37%
  • Private Company1.22%
  • Endowment Fund0.26%
  • Government Pension Fund0.24%

Reported short interest has fallen from 12.05% to 10.22% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +3,217,592 15.5%
BlackRock Mutual Fund 2026/Q3 +1,540,922 8.1%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +1,486,482 2.5%
Artal Group S.A. VC/PE Fund 2026/Q3 +1,000,000 1.9%
Franklin Resources Mutual Fund 2026/Q3 +979,843 3.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +853,287 3.9%
Deutsche Asset & Wealth Management Mutual Fund 2026/Q3 +515,778 0.8%
Jane Street Group, LLC Private Company 2026/Q3 +435,666 0.6%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +324,916 2.1%
Universal Investment GmbH Mutual Fund 2026/Q3 +247,076 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +174,872 0.2%
TD Asset Management Mutual Fund 2026/Q3 +165,030 0.1%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +1,667,888 1.4%
Alyeska Investment Group, L.P. Hedge Fund 2026/Q3 +1,053,015 0.8%
Morgan Stanley Public Company 2026/Q3 +950,246 2.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 James Frates Chief Financial Officer Derivative Exercise and Sale -40,000 $30.97 227,434
8 Nov 2026 Joshua Cohen Co-Chief Executive Officer Automatic Disposition -100,000 $30.11 3,053,336
8 Nov 2026 Justin Klee Co-Chief Executive Officer Automatic Disposition -100,000 $30.11 3,053,269
4 Oct 2026 George Milne Independent Chairperson Automatic Disposition -30,000 $27.70 782,881
9 Sep 2026 James Frates Chief Financial Officer Private Disposition -1,042 $33.23 227,434
9 Sep 2026 James Frates Chief Financial Officer Open Market Disposition -9,768 $32.27 227,434
9 Sep 2026 Camille Bedrosian Chief Medical Officer Private Disposition -2,081 $33.09 101,592
9 Sep 2026 Camille Bedrosian Chief Medical Officer Open Market Disposition -7,947 $32.21 101,592
9 Sep 2026 Joshua Cohen Co-Chief Executive Officer Private Disposition -919 $33.15 3,153,336
9 Sep 2026 Joshua Cohen Co-Chief Executive Officer Open Market Disposition -29,545 $32.16 3,153,336
9 Sep 2026 Justin Klee Co-Chief Executive Officer Private Disposition -1,439 $33.16 3,153,269
9 Sep 2026 Justin Klee Co-Chief Executive Officer Open Market Disposition -29,025 $32.13 3,153,269
9 Sep 2026 Gina Mazzariello Chief Legal Officer & General Counsel Private Disposition -11 $33.34 45,373
9 Sep 2026 Gina Mazzariello Chief Legal Officer & General Counsel Open Market Disposition -9,525 $32.46 45,373
30 Aug 2026 Karen Firestone Independent Director Derivative Exercise and Retained +50,000 $5.05 116,900
17 Aug 2026 James Frates Chief Financial Officer Other Acquisition +22,807 – 238,244
17 Aug 2026 Camille Bedrosian Chief Medical Officer Other Acquisition +22,807 – 111,620
17 Aug 2026 Joshua Cohen Co-Chief Executive Officer Other Acquisition +60,039 – 3,183,800
17 Aug 2026 Justin Klee Co-Chief Executive Officer Other Acquisition +60,039 – 3,183,733
17 Aug 2026 Gina Mazzariello Chief Legal Officer & General Counsel Other Acquisition +21,284 – 54,909

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 12,823,384 10.2% 10.5
15 Oct 2026 13,249,442 10.6% 9.9
30 Sep 2026 12,666,971 10.1% 9.2
15 Sep 2026 13,512,753 12.1% 8.6
31 Aug 2026 12,737,201 11.4% 2.4
14 Aug 2026 13,425,106 12.0% 7.1

Discussion

No comments yet — be the first to weigh in on AMLX.

Sign in to join the discussion.

Scroll to Top